daunorubicin has been researched along with Dermatitis Medicamentosa in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Braniecki, M; Gok Yavuz, B; Hwang, J; Quigley, JG; Singh, N; Tsoukas, MM | 1 |
| Bennett, D; Drago, MJ; Elder, D; Kim, BS; Rosenbach, M | 1 |
| Hill, A; Pol, RR; Wright, A | 1 |
| Fernández-Durán, DA; Grande, C; Revenga Arranz, F; Rodríguez Peralto, JL; Vanaclocha Sebastián, F | 1 |
| Helm, KF; Long, D; Williams, JV | 1 |
| Akasya, E; Büyükbabani, N; Diz-Küçükkaya, R; Oncü, S; Ozkaya-Bayazit, E; Pekçelen, Y | 1 |
| Bachur, N; Benjamin, R; Greene, W; Huffman, D; Schimpff, S; Wiernik, PH | 1 |
1 trial(s) available for daunorubicin and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Omacetaxine added to a standard acute myeloid leukaemia chemotherapy regimen reduces cellular FLIP levels, markedly increasing the incidence of eccrine hidradenitis.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Cyclophosphamide; Cytarabine; Daunorubicin; Down-Regulation; Drug Eruptions; Hidradenitis; Homoharringtonine; Humans; Incidence; Leukemia, Myeloid, Acute; Mercaptopurine; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Neutrophils; Protein Kinase Inhibitors; Sweat Glands | 2021 |
6 other study(ies) available for daunorubicin and Dermatitis Medicamentosa
| Article | Year |
|---|---|
All-trans-retinoic acid-induced scrotal ulcers in a patient with acute promyelocytic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Eruptions; Humans; Leukemia, Promyelocytic, Acute; Male; Scrotum; Skin Ulcer; Tretinoin | 2013 |
Daunorubicin-induced hyperpigmentation.
Topics: Antibiotics, Antineoplastic; Daunorubicin; Drug Eruptions; Humans; Hyperpigmentation; Leukemia, Myeloid, Acute; Male; Middle Aged | 2010 |
Acute and painful erythema of the hands and feet. Acral erythema induced by chemotherapy.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Eruptions; Erythema; Female; Foot Dermatoses; Hand Dermatoses; Humans; Middle Aged; Pain | 1997 |
Chemotherapy-induced inflammation in seborrheic keratoses mimicking disseminated herpes zoster.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cytarabine; Daunorubicin; Diagnosis, Differential; Drug Eruptions; Female; Herpes Zoster; Humans; Keratosis, Seborrheic; Leukemia, Myeloid, Acute; Skin; Substance Withdrawal Syndrome | 1999 |
Bullous acral erythema and concomitant pigmentation on the face and occluded skin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Daunorubicin; Drug Eruptions; Erythema; Female; Hand Dermatoses; Humans; Hyperpigmentation; Leukemia, Myeloid; Skin Diseases, Vesiculobullous | 2000 |
High-dose daunorubicin therapy for acute nonlymphocytic leukemia: correlation of response and toxicity with pharmacokinetics and intracellular daunorubicin reductase activity.
Topics: Adult; Aged; Alopecia; Bone Marrow; Bone Marrow Cells; Daunorubicin; Drug Eruptions; Erythrocytes; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Leukocyte Count; Leukocytes; Male; Middle Aged; Oxidoreductases; Pharyngitis; Prognosis; Remission, Spontaneous; Vomiting | 1972 |